Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis.

Ramey DR, Watson DJ, Yu C, Bolognese JA, Curtis SP, Reicin AS.

Curr Med Res Opin. 2005 May;21(5):715-22.

PMID:
15974563
2.

A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.

Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S; Pediatric Rheumatology International Trials Organization..

Arthritis Rheum. 2005 Feb;52(2):563-72.

3.

Hemophilic arthropathy.

Luck JV Jr, Silva M, Rodriguez-Merchan EC, Ghalambor N, Zahiri CA, Finn RS.

J Am Acad Orthop Surg. 2004 Jul-Aug;12(4):234-45. Review.

PMID:
15473675
4.

Etoricoxib.

Matsumoto AK, Cavanaugh PF Jr.

Drugs Today (Barc). 2004 May;40(5):395-414. Review.

PMID:
15319795
5.

Acetaminophen as symptomatic treatment of pain from osteoarthritis.

Bertin P, Keddad K, Jolivet-Landreau I.

Joint Bone Spine. 2004 Jul;71(4):266-74. Review.

PMID:
15288850
6.

Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.

Birbara CA, Puopolo AD, Munoz DR, Sheldon EA, Mangione A, Bohidar NR, Geba GP; Etoricoxib Protocol 042 Study Group..

J Pain. 2003 Aug;4(6):307-15.

PMID:
14622687
7.

Characterization of etoricoxib, a novel, selective COX-2 inhibitor.

Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, Wong P, DeTora L, Gertz B, Agrawal N, Wagner J, Gottesdiener K.

J Clin Pharmacol. 2003 Jun;43(6):573-85.

PMID:
12817520
8.

Consensus perspectives on prophylactic therapy for haemophilia: summary statement.

Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C.

Haemophilia. 2003 May;9 Suppl 1:1-4.

PMID:
12709030
9.

Blood-induced joint damage in hemophilia.

Roosendaal G, Lafeber FP.

Semin Thromb Hemost. 2003 Feb;29(1):37-42. Review.

PMID:
12640563
10.

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, Yu Q, Bombardier C.

Gastroenterology. 2003 Feb;124(2):288-92.

PMID:
12557133
11.

Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib.

Hunt RH, Harper S, Callegari P, Yu C, Quan H, Evans J, James C, Bowen B, Rashid F.

Aliment Pharmacol Ther. 2003 Jan;17(2):201-10.

12.

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ; Protocol 007 Study Group..

Rheumatology (Oxford). 2002 Sep;41(9):1052-61. Erratum in: Rheumatology (Oxford). 2003 Jun;42(6):814.

PMID:
12209041
13.

Current treatment of hemophilic arthropathy.

Hilgartner MW.

Curr Opin Pediatr. 2002 Feb;14(1):46-9. Review.

PMID:
11880733
14.

A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.

Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, Luta G, Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA, Kremer JM, Lautzenheiser RL, Markenson JA, Schnitzer TJ, Weaver A, Cummins P, Wilson A, Morant S, Fort J.

Arthritis Rheum. 2001 Jul;44(7):1587-98.

15.

The hemophilias--from royal genes to gene therapy.

Mannucci PM, Tuddenham EG.

N Engl J Med. 2001 Jun 7;344(23):1773-9. Review. No abstract available. Erratum in: N Engl J Med 2001 Aug 2;345(5):384.

PMID:
11396445
16.

Renal effects of COX-2-selective inhibitors.

Brater DC, Harris C, Redfern JS, Gertz BJ.

Am J Nephrol. 2001 Jan-Feb;21(1):1-15. Review.

PMID:
11275626
17.
18.

Opioid analgesics: comparative features and prescribing guidelines.

Cherny NI.

Drugs. 1996 May;51(5):713-37. Review.

PMID:
8861543
19.

Gastrointestinal bleeding in hemophilia as a complication of the use of over the counter non-steroidal anti-inflammatory drugs.

Cagnoni PJ, Aledort L.

Am J Hematol. 1994 Dec;47(4):336-7. No abstract available.

PMID:
7977313
20.

Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Boardman PL, Hart FD.

Br Med J. 1967 Nov 4;4(5574):264-8. No abstract available.

Items per page

Supplemental Content

Support Center